1. Leptospira seroprevalence in owned dogs from Spain. Issue 8 (August 2019) Authors: López, M.C.; Vila, A.; Rodón, J.; Roura, X. Journal: Heliyon Issue: Volume 5:Issue 8(2019) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. 342 A Phase Ib/II study of alpelisib (BYL719) and ganitumab (AMG 479) in adult patients with selected advanced solid tumors. (September 2015) Authors: Juric, D.; Rodón, J.; Bauer, T.M.; Wainberg, Z.; Tolaney, S.; Modi, S.; Martín, A. González; Hengelage, T.; Melendez, M.; Choudhury, S.; Nauwelaerts, H.; Bedard, P.L. Journal: European journal of cancer Issue: Volume 51:(2015)Supplement 3 Page Start: S68 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Subasumstat, a first-in-class inhibitor of SUMO-activating enzyme, demonstrates dose-dependent target engagement and SUMOylation inhibition, leading to rapid activation of innate and adaptive immune responses in the dose escalation portion of a phase 1/2 clinical study. (October 2022) Authors: Saggu, G.; Stroopinsky, D.; Dudek, A.Z.; Olszanski, A.J.; Juric, D.; Dowlati, A.; Vaishampayan, U.; Assad, H.; Rodón, J.; Gibbs, J.; Green, J.; Du, Z.; Rudicell, R.; Kannan, K.; Gharavi, R.; Gomez-Pinillos, A.; Fram, R.J.; Berger, A.; Sachsenmeier, K.; Kasar, S. Journal: European journal of cancer Issue: Volume 174(2022)Supplement 1 Page Start: S125 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗